Membranal tyrosine protein kinase activity (but not cAMP-dependent protein kinase activity) is associated with growth of rat mammary tumors.
DMBA induced rat mammary tumors were used to study the association of tyrosine protein kinase activity with tumor growth. Pharmacological manipulations of blood prolactin level, by perphenazine and bromocriptine, were used to stimulate or arrest tumor growth, respectively. During perphenazine treatment, a 2-3-fold increase in membranal tyrosine protein kinase activity, measured with angiotensin II as substrate, preceded the 3-4-fold increase in tumor area. At the same time the cAMP-dependent protein kinase activity, measured with kemptide as substrate, did not change.
Sharoni
Y
Y
Radian
S
S
Levy
J
J
D015127:9,10-Dimethyl-1,2-benzanthracene; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D002455:Cell Division; D000242:Cyclic AMP / Q000494:pharmacology; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000201:enzymology* / Q000473:pathology; D008566:Membranes / Q000201:enzymology; D009842:Oligopeptides / Q000378:metabolism; D010546:Perphenazine / Q000494:pharmacology; D011388:Prolactin / Q000097:blood; D011494:Protein Kinases / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases; D011794:Quercetin / Q000494:pharmacology; D051381:Rats
D009842:Oligopeptides; D000804:Angiotensin II; D015127:9,10-Dimethyl-1,2-benzanthracene; C037642:kemptide; D011388:Prolactin; D011794:Quercetin; D000242:Cyclic AMP; D011494:Protein Kinases; D011505:Protein-Tyrosine Kinases; D010546:Perphenazine